Meprobamate
Meprobamate Tablets USP
Approved
Approval ID
e9aa3d4c-f2e9-4ca9-b563-85fac4024539
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jul 19, 2011
Manufacturers
FDA
Taro Pharmaceutical Industries Ltd.
DUNS: 600072078
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Meprobamate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code52549-4148
Application NumberANDA200998
Product Classification
M
Marketing Category
C73584
G
Generic Name
Meprobamate
Product Specifications
Route of AdministrationORAL
Effective DateJuly 19, 2011
FDA Product Classification
INGREDIENTS (5)
MeprobamateActive
Quantity: 400 mg in 1 1
Code: 9I7LNY769Q
Classification: ACTIB
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT
silicon dioxideInactive
Code: ETJ7Z6XBU4
Classification: IACT
cellulose, microcrystallineInactive
Code: OP1R32D61U
Classification: IACT
stearic acidInactive
Code: 4ELV7Z65AP
Classification: IACT
Meprobamate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code52549-4147
Application NumberANDA200998
Product Classification
M
Marketing Category
C73584
G
Generic Name
Meprobamate
Product Specifications
Route of AdministrationORAL
Effective DateJuly 19, 2011
FDA Product Classification
INGREDIENTS (5)
silicon dioxideInactive
Code: ETJ7Z6XBU4
Classification: IACT
cellulose, microcrystallineInactive
Code: OP1R32D61U
Classification: IACT
MeprobamateActive
Quantity: 200 mg in 1 1
Code: 9I7LNY769Q
Classification: ACTIB
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT
stearic acidInactive
Code: 4ELV7Z65AP
Classification: IACT